.jpg?width=1754&height=637&name=SP_Logo_Color_RGB%202020update%20(1).jpg "Orsini Specialty Pharmacy Logo"){kind=logo}
KERATOCONUS DISEASE
TREATMENT
About the Disease
Keratoconus is a rare, degenerative eye condition that occurs when the normally dome-shaped cornea weakens and begins to bulge into a cone-like shape resulting in vision loss. Keratoconus often appears in individuals who are in their late teens to early 20s and occurs in approximately 1 out of every 2,000 people in the US.
About our Patient Care
Our dedicated Care Team will work with the physician's office and insurance on a patient's behalf so that patients have more time to focus on their treatment and quality of life. We are here to listen, provide counseling on treatment, including side-effect management, and assist with sourcing third-party financial assistance.
As part of treatment, we provide:
Dedicated Care Team
We provide prescribers and patients with a dedicated care team for each of our disease state programs. This includes a primary pharmacy contact, clinical education, side-effects management, scheduled refill calls, and a direct phone, fax and email address.
Shipping and Coordination of Care
We provide free overnight delivery of medications and necessary medical supplies and manage the coordination of care between prescribers, sites of care, nurses and patients to ensure dispenses and drug delivery align with the date and location of service.
Financial Assistance Coordination
We successfully identify and assist enrolling patients into any and all manufacturer co-pay and foundation support programs in order to minimize a potential financial burden to patients given the high-cost of specialty medications.
24/7 Access to a Pharmacist
We provide prescribers and patients access to a pharmacist 24/7 to ensure patients are always cared for.
Supported Treatments
Click on the specialty drug name below to expand and see more information.
Photrexa® (riboflavin 5’-phosphate ophthalmic solution)
Brand Name | Photrexa® (riboflavin 5’-phosphate ophthalmic solution)
Manufacturer | Glaukos® Corporation
Route of Administration | Ophthalmic Solution
Approved Indication | For the treatment of patients with progressive keratoconus and corneal ectasia following refractive surgery
Self-Administration | No
Product Website | https://www.glaukos.com/corneal-health
Photrexa® Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution)
Brand Name | Photrexa® Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution)
Manufacturer | Glaukos® Corporation
Route of Administration | Ophthalmic Solution
Approved Indication | For the treatment of patients with progressive keratoconus and corneal ectasia following refractive surgery
Self-Administration | No
Product Website | https://www.glaukos.com/corneal-health
Partnering with Prescribers
Licensed prescribers can submit a completed enrollment form directly to our Admission team. We will begin the process and communicate with your office every step of the way.
